Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Paul A. Romness M.P.H. | Founder, Chairman, President & CEO | 680k | -- | 1967 |
| Mr. Christopher P. Acevedo | Chief Financial Officer | 36k | -- | 1964 |
| Dr. Robert G. Petit Ph.D. | Chief Medical Officer & Chief Scientific Officer | 420k | -- | 1960 |
| Mr. Jack Doll | Chief of Staff | -- | -- | -- |
| Mr. Gerald E. Commissiong | Chief Business Officer | -- | -- | 1983 |
OS Therapies Incorporated
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 4
Description
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
February 7, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
February 5, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
February 4, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
January 31, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission